O. Gershanik Et Al. , "Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study," PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.27, no.6, pp.963-971, 2003
Gershanik, O. Et Al. 2003. Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.27, no.6 , 963-971.
Gershanik, O., Emre, M., Bernhard, G., & Sauer, D., (2003). Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.27, no.6, 963-971.
Gershanik, O Et Al. "Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study," PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.27, no.6, 963-971, 2003
Gershanik, O Et Al. "Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study." PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.27, no.6, pp.963-971, 2003
Gershanik, O. Et Al. (2003) . "Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study." PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.27, no.6, pp.963-971.
@article{article, author={O Gershanik Et Al. }, title={Efficacy and safety of levodopa patients suboptimally controlled with entacapone in Parkinson's disease with levodopa alone, in daily clinical practice: An international, multicentre, open-label study}, journal={PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY}, year=2003, pages={963-971} }